Black Sash and COSATU call for a grant for all children
Black Sash and COSATU have made recommendations to the Committee and have called for a grant that is accessible to all children
Black Sash and COSATU have made recommendations to the Committee and have called for a grant that is accessible to all children
Sadly, it would seem, that many healthworkers serving in clinics and hospitals around South Africa stigmatise and ridicule people with HIV/AIDS. When one woman in the Western Cape spoke out about it at a meeting recently, the room resounded with echoes of similar stories. Sue Valentine reports. [This feature was first broadast on "AM Live" on SAfm on Thursday March 1, 2001. Speaking on the programme immediately after this report was played, a spokesperson for G F Jooste Hospital denied that staff at his institution discriminated against people with HIV/AIDS. On the contrary, he said, his staff were trained to deal with patients sympathetically and with kindness.]

Renowned author John le Carre delves into the dark and dangerous world of drug trials and pharmaceutical profits in his latest novel, "The Constant Gardener". In the afterword to the book he says that although his novel is a work of fiction and doesn'€™t reflect the actions of any real people, the real goings-on in the industry make his story seem like a "holiday postcard". Sue Valentine spoke to him, this is a transcript of part of their conversation.
One of the world'€™s pharmarceutical giants, Pfizer, was a notable absentee among the litigants represented by the Pharmaceutical Manufacturers'€™ Association when they took the South African government to court this week.
This week in our regular feature, spy-master novelist John le Carre shares his thoughts on the pharmaceutical industry and we meet a South African who's gained access to medication through volunteering for drug trials.

Scientists have completed their laboratory research on a potential HIV vaccine for South Africa and the process is underway to begin human trials later this year. Kerry Cullinan reports.
Problems with learning that affect many young children may be a problem with teachers rather than learners. Formal teaching tends to favour verbal learners, ignoring the needs of children who are "visual learners" and whose thinking is dominated by the right hemisphere of the brain which processes information in pictures.

One person is sure to be at the forefront-  putting the view of business across - when government and the pharmaceutical industry tackle one another in  the much hyped court case. But is Mirryena Deeb  really the Cruella de Ville of the industry or is she just a woman caught up in the demands of trying to juggle a stressful job, motherhood and a sick nation calling louder and louder for medicine to ease its pain...Anso Thom from Health-e News Service spoke to her.
It has been almost two and a half years since Parliament passed the Medicines and Related Substances Control Amendment Act on October 31, 1997. During this time the legislation has been tied up in litigation instituted by the Pharmaceutical Manufacturers' Association who argue that their patent rights will be ignored by section 15c of the new law. AIDS activists around the world have thrown their weight behind the South African government in its bid to create a legal framework to ensure more affordable drugs.
HIV infection, if it remains uncontrolled, has the potential to swamp progress made in tuberculosis (TB) control, according to the South African Health Review released today.
A collection of quotes on what those involved in the court case and those most likely to be affected have to say.
Despite praising the Department of Health for effectively managing malaria, the South African Health Review today warned that there had been a dramatic rise since 1996.
The impact of HIV/AIDS on all aspects of South African society is hampering even the best efforts to improve the health status of the country and overall the country'€™s health status remains poor.

Living with HIV for eight years without picking up an opportunistic infection, Lundi Ntikinca is worried about the day when he will need expensive medication that could save his life. An option he cannot afford.
The sale of drugs in South Africa earned pharmaceutical companies about R8,25-billion last year, but the public sector only accounted for 24 percent of sales despite the fact that over 80 percent of the population depends on state health.